Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Sarcoma, Kaposi 3Skin Neoplasms 2HIV Infections 2Sarcoma 1Rectal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

Doxorubicin 5tecogalan 4Liposomes 4Vincristine 3Bleomycin 3Mitoxantrone 2ziconotide 1vesnarinone 1tin etiopurpurin 1human papillomavirus vaccine, L1 type 16, 18 1Zidovudine 1Tumor Necrosis Factor-alpha 1Sugars 1Semaxinib 1Ro 24-7429 1Ritonavir 1Paclitaxel 1Mitoguazone 1Maraviroc 1Maltose 1Interferon-alpha 1Inosine Pranobex 1Etoposide 1Daunorubicin 1Cidofovir 1Bexarotene 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Acquired Immunodeficiency Syndrome × Semaxinib × Clear all
NCT00005931 2005-06-24

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
30 enrolled
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡